VJRegenMed is committed to improving our service to you

Share this video  

VJRegenMed is committed to improving our service to you

Advanced Therapies Week 2022 | Increasing patient recruitment to rare disease trials

Will Chou, MD, Aruvant, New York, NY, provides his insights on approaches to solve recruitment issues in clinical trials for rare diseases such as sickle cell disease (SCD). He emphasizes the need to gain the trust of patients, who may not necessarily be knowledgeable of every aspect of the therapy, as well as being transparent with everyone involved in the trials. This interview took place at Advanced Therapies Week 2022.

Disclosures

Will Chou, MD, is an employee of Aruvant.